Duke Blood Cancer Center — Durham, North Carolina

Duke Blood Cancer Center is a clinical research site located in Durham, North Carolina, United States 27705.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Duke Blood Cancer Center has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Systemic Mastocytoses, Indolent, Systemic Mastocytoses, Aggressive, Acute Myeloid Leukemia.

Sponsors: Cogent Biosciences, Inc., Kura Oncology, Inc., Duke University.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Blood Cancer Center?

Duke Blood Cancer Center has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Blood Cancer Center conducted?

Duke Blood Cancer Center has 5 clinical trials on record, with 2 currently active. Their work covers Systemic Mastocytoses, Indolent, Systemic Mastocytoses, Aggressive, Acute Myeloid Leukemia.

Is Duke Blood Cancer Center accredited by Crixeo Health?

Duke Blood Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Blood Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.